Rare Disease Advocates
501C3 Nonprofit Organization Information
Rare Disease Advocates is a 501(c)(3) charitable nonprofit in Los Angeles, California (EIN 99-3548319). It has been tax-exempt since September 2024, and contributions to it are tax-deductible. Its Form 990-EZ for tax year 2024 reports total revenue of $123,833 and net assets of $7,225. TaxExemptWorld has Form 990s on file for 1 tax year (2024). The IRS classifies its activity as Public Health Program (NTEE E70). It is one of 26,710 nonprofits in Los Angeles, CA.
Form 990-EZ · Tax period ending Dec 2024 · Filed Oct 4, 2025 · From the IRS e-file data
Dollar amounts for every revenue and expense line are in the full 990 report.
Mission (as filed): AT RARE DISEASE ADVOCATES ORGANIZATION, OUR MISSION IS TO EMPOWER AND UPLIFT INDIVIDUALS IMPACTED BY RARE DISEASES. RARE DISEASE ADVOCATES IS A NON-PROFIT ORGANIZATION DEDICATED TO RAISING PROVIDER AWARENESS, PROVIDING PATIENT SUPPORT, AND ADVOCATING FOR BETTER RESOURCES AND RESEARCH FOR THOSE LIVING WITH RARE MEDICAL CONDITIONS.WE SERVE HEALTH CARE PROVIDERS AROUND THE COUNTRY BUT PRIMARILY FOCUSING ON SOUTHERN CALIFORNIA BY CONDUCTING EDUCATIONAL SEMINARS AND PROVIDING FINANCIAL SUPPORT TO RARE DISEASE PATIENTS. THERE ARE OVER TEN THOUSAND RARE DISEASES. RARE DISEASES ARE ESTIMATED TO AFFECT MORE THAN THIRTY MILLION PEOPLE IN THE UNITED STATES. EACH DISEASE MAY BE RARE INDIVIDUALLY, BUT PEOPLE WITH RARE DISEASES OFTEN FACE SIMILAR CHALLENGES. THESE CHALLENGES MAY INCLUDE ACCESSING INFORMATION, GETTING A DIAGNOSIS, AND FINDING RESOURCES.OUR ORGANIZATION'S THREE PRIMARY OBJECTIVES:RAISE AWARENESS, PROVIDE SUPPORT AND ADVOCATE FOR CHANGE
EDUCATIONAL CONFERENCE SERIES ON PNH AND MDS: FROM AUGUST TO NOVEMBER 2024, RARE DISEASE ADVOCATES LAUNCHED A SERIES OF EDUCATIONAL SEMINARSFOCUSED ON PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) AND MYELODYSPLASTIC SYNDROMES (MDS). EACHEVENT FEATURED A CLINICAL PRESENTATION LED BY A PHARMD AND MD TEAM, DELIVERED TO A TARGETED AUDIENCE OFHEALTHCARE PROFESSIONALS INCLUDING PHYSICIANS, FELLOWS, NURSE PRACTITIONERS, AND PHARMACISTS. THESESESSIONS EMPHASIZED DIAGNOSTIC CHALLENGES, DISEASE PROGRESSION, AND EMERGING TREATMENT STRATEGIES TOIMPROVE AWARENESS AND CLINICAL OUTCOMES FOR THESE RARE HEMATOLO…
EDUCATIONAL CONFERENCE SERIES ON MYELOFIBROSIS, AML, AND BPDCN: THE FINAL EDUCATIONAL EVENT IN DECEMBER 2024 FOCUSED ON MYELOFIBROSIS (MF), ACUTE MYELOID LEUKEMIA(AML), AND BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN). LIKE PRIOR CONFERENCES, THE SESSION WAS PRESENTED BY A PHARMD AND MD TEAM TO A TARGETED AUDIENCE OF HEALTHCARE PROFESSIONALS INCLUDING PHYSICIANS, FELLOWS, NURSE PRACTITIONERS, AND PHARMACISTS. THE GOAL WAS TO PROVIDE EDUCATION ON THE LATEST TREATMENT STRATEGIES, IMPROVE DISEASE RECOGNITION, AND HIGHLIGHT PATIENT CARE CONSIDERATIONS SPECIFIC TO THESE RARE HEMATOLOGIC MA…
ORGANIZATIONAL INFRASTRUCTURE DEVELOPMENT: IN ITS FOUNDATIONAL YEAR, RARE DISEASE ADVOCATES FOCUSED ON ESTABLISHING THE INTERNAL INFRASTRUCTUREREQUIRED TO SUPPORT LONG-TERM, MISSION-ALIGNED PROGRAMMING. THIS INCLUDED DEVELOPING AND LAUNCHINGTHE ORGANIZATION'S OFFICIAL WEBSITE, SETTING UP A DONATION PORTAL AND NONPROFIT BANK ACCOUNT, AND INITIATING PARTNERSHIPS WITH SEVERAL PHARMACEUTICAL SPONSORS. THESE EFFORTS LAID A STRONG GROUNDWORK FOROPERATIONAL EFFICIENCY, DONOR ENGAGEMENT, AND STRATEGIC GROWTH IN THE RARE DISEASE ADVOCACY SPACE.
Public charity (509(a)(2))
Prepared by TaxExemptWorld from IRS Form 990-EZ e-file data (object ID 202542779349200109). Not an official IRS form.